FUTURE MICROBIOLOGY

dc.creatorGil, Fernando
dc.creatorCalderón, Iván L
dc.creatorFuentes, Juan A
dc.creatorParedes-Sabja, Daniel Gonzalo
dc.date2021-08-23T22:53:38Z
dc.date2022-07-08T20:39:55Z
dc.date2021-08-23T22:53:38Z
dc.date2022-07-08T20:39:55Z
dc.date2018
dc.date.accessioned2023-08-23T00:30:18Z
dc.date.available2023-08-23T00:30:18Z
dc.identifier1151025
dc.identifier1151025
dc.identifierhttps://hdl.handle.net/10533/251221
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8355390
dc.descriptionClostridioides difficile (C. difficile) has become a pathogen of worldwide importance considering that epidemic strains are disseminated in hospitals of several countries, where community-acquired infections act as a constant source of new C. difficile strains into hospitals. Despite the advances in the treatment of infections, more effective therapies against C. difficile are needed but, at the same time, these therapies should be less harmful to the resident gastrointestinal microbiota. The purpose of this review is to present a description of issues associated to C. difficile infection, a summary of current therapies and those in developmental stage, and a discussion of potential combinations that may lead to an increased efficacy of C. difficile infection treatment.
dc.descriptionRegular 2015
dc.descriptionFONDECYT
dc.descriptionFONDECYT
dc.languageeng
dc.relationhandle/10533/111557
dc.relationhandle/10533/111541
dc.relationhandle/10533/108045
dc.relationhttps://doi.org/10.2217/fmb-2017-0203
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsinfo:eu-repo/semantics/article
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleClostridioides (Clostridium) difficile infection: current and alternative therapeutic strategies
dc.titleFUTURE MICROBIOLOGY
dc.typeArticulo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución